Effective Management of 177Lu-DOTA0-Tyr3-Octreotate Extravasation

Archive ouverte

Maucherat, Bruno | Varmenot, Nicolas | Fleury, Vincent | Senellart, Helene | Rousseau, Caroline

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. Radiopharmaceutical extravasation is a known nuclear medicine adverse effect, mostly with no complication in case of diagnostic radiopharmaceutical. However, a therapeutic radiopharmaceutical extravasation may have clinical consequences and must be treated quickly and effectively. We report here a case of 177Lu-DOTA0-Tyr3-octreotate extravasation.

Consulter en ligne

Suggestions

Du même auteur

68 Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making and long-term benefits

Archive ouverte | Rousseau, Caroline | CCSD

International audience

COVID-19 vaccination may cause FDG uptake beyond axillary area

Archive ouverte | Fleury, Vincent | CCSD

International audience. Background: The vaccination immune response may induce false-positive 18F-FDG PET/CT uptake.Case presentation: An extended supraclavicular lymph nodal activation after coronavirus disease 201...

Is Glucagon Administration Compatible With FDG PET/MRI?

Archive ouverte | Maucherat, Bruno | CCSD

International audience. Digestive peristalsis generates many artifacts that limit the abdominal and pelvic MRI interpretation. Apart from the hypoglycemia treatment in patients with diabetes, glucagon analog is also...

Chargement des enrichissements...